The Department of Veterans Affairs National Acquisition Center awarded Golden State Medical Supply, Inc. a single-award indefinite delivery contract with a potential value of $11.56 million to supply warfarin sodium tablets. The contract's base period is from May 16, 2020 to May 15, 2021, with four one-year option periods extending to May 15, 2025.
The contract facilitates orders from VA, DoD, Bureau of Prisons, and Indian Health Service for an estimated 123,000 bottles of warfarin sodium tablets per year in various dosage forms and package sizes. The tablets will be distributed through the VA and DoD Pharmaceutical Prime Vendor programs to supply VA hospitals, DoD medical treatment facilities, federal prisons, and Indian Health centers on an as-needed basis. The original pre-solicitation notice indicated plans to competitively solicit offers to provide an uninterrupted supply of these medications, which are commonly used to treat and prevent blood clots and thromboembolic disorders in veterans receiving medical care through VA and other government health programs.
Generated 3/14/24, 9:37 AM